Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

How important is HER2/neu amplification and expression when selecting patients for HER2/neu-targeted therapies?

Davol PA, Lum LG.

Clin Breast Cancer. 2004 Apr;5(1):70-1. No abstract available.

PMID:
15140288
2.

The use of HER2 testing in the management of breast cancer.

Ravdin P.

Semin Oncol. 2000 Oct;27(5 Suppl 9):33-42. Review.

PMID:
11049055
3.

Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing.

Cell Markers And Cytogenetics Committees College Of American Pathologists.

Arch Pathol Lab Med. 2002 Jul;126(7):803-8. Review.

PMID:
12088449
4.

Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.

Ballinger TJ, Sanders ME, Abramson VG.

Clin Breast Cancer. 2015 Jun;15(3):171-80. doi: 10.1016/j.clbc.2014.11.009. Epub 2014 Dec 2. Review.

PMID:
25516402
5.
6.

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas.

Rosa FE, Santos RM, Rogatto SR, Domingues MA.

Braz J Med Biol Res. 2013 Mar;46(3):207-16. Epub 2013 Mar 19. Review.

Supplemental Content

Support Center